These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28834396)

  • 1. Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta-analysis of randomized trials.
    Silvetti S; Belletti A; Fontana A; Pollesello P
    ESC Heart Fail; 2017 Nov; 4(4):595-604. PubMed ID: 28834396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study.
    García-González MJ; Aldea Perona A; Lara Padron A; Morales Rull JL; Martínez-Sellés M; de Mora Martin M; López Díaz J; López Fernandez S; Ortiz Oficialdegui P; Jiménez Sosa A
    ESC Heart Fail; 2021 Dec; 8(6):4820-4831. PubMed ID: 34716753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry.
    Dobarro D; Donoso-Trenado V; Solé-González E; Moliner-Abós C; Garcia-Pinilla JM; Lopez-Fernandez S; Ruiz-Bustillo S; Diez-Lopez C; Castrodeza J; Méndez-Fernández AB; Vaqueriza-Cubillo D; Cobo-Marcos M; Tobar J; Sagasti-Aboitiz I; Rodriguez M; Escolar V; Abecia A; Codina P; Gómez-Otero I; Pastor F; Marzoa-Rivas R; González-Babarro E; de Juan-Baguda J; Melendo-Viu M; de Frutos F; Gonzalez-Costello J
    ESC Heart Fail; 2023 Apr; 10(2):1193-1204. PubMed ID: 36655614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-inflammatory and haemodynamic effects of levosimendan on advanced heart failure patients: a meta-analysis of published studies.
    Zhou S; Li D; Zhang L; Li J
    J Int Med Res; 2023 Jul; 51(7):3000605221148402. PubMed ID: 37490021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered.
    Sanfilippo F; La Via L; Merola F; Astuto M
    Cardiol J; 2021; 28(5):798-799. PubMed ID: 34240399
    [No Abstract]   [Full Text] [Related]  

  • 6. Repeated Levosimendan Infusions in the Management of Advanced Heart Failure: Review of the Evidence and Meta-analysis of the Effect on Mortality.
    Silvetti S; Pollesello P; Belletti A
    J Cardiovasc Pharmacol; 2024 Feb; 83(2):144-157. PubMed ID: 37991393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan improves the acute course of takotsubo syndrome: a pooled analysis.
    Jaguszewski MJ; Gasecka A; Hering D; Filipiak KJ; Szarpak L; Fijałkowski M; Gruchała M
    ESC Heart Fail; 2021 Oct; 8(5):4360-4363. PubMed ID: 34342162
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
    Comín-Colet J; Manito N; Segovia-Cubero J; Delgado J; García Pinilla JM; Almenar L; Crespo-Leiro MG; Sionis A; Blasco T; Pascual-Figal D; Gonzalez-Vilchez F; Lambert-Rodríguez JL; Grau M; Bruguera J;
    Eur J Heart Fail; 2018 Jul; 20(7):1128-1136. PubMed ID: 29405611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levosimendan in patients with acute decompensated heart failure : A meta-analysis.
    Zhou S; Zhang L; Li J
    Herz; 2019 Nov; 44(7):630-636. PubMed ID: 29637229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure.
    Delgado JF; Oliva F; Reinecke A
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C8-C14. PubMed ID: 29249905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.
    Pölzl G; Allipour Birgani S; Comín-Colet J; Delgado JF; Fedele F; García-Gonzáles MJ; Gustafsson F; Masip J; Papp Z; Störk S; Ulmer H; Vrtovec B; Wikström G; Altenberger J
    ESC Heart Fail; 2019 Feb; 6(1):174-181. PubMed ID: 30378288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan.
    Agostoni P; Farmakis DT; García-Pinilla JM; Harjola VP; Karason K; von Lewinski D; Parissis J; Pollesello P; Pölzl G; Recio-Mayoral A; Reinecke A; Yerly P; Zima E
    Card Fail Rev; 2019 Nov; 5(3):155-161. PubMed ID: 31768272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive levosimendan treatment in the management of advanced heart failure.
    Oliva F; Comin-Colet J; Fedele F; Fruhwald F; Gustafsson F; Kivikko M; Borbély A; Pölzl G; Tschöpe C
    Eur Heart J Suppl; 2018 Dec; 20(Suppl I):I11-I20. PubMed ID: 30555280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of simendan in the treatment of acute heart failure and its impact on NT-proBNP.
    Li J; Wang XY; Yang ZY; Li Y; Yang F; Yuan P; Yang J
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4027-4032. PubMed ID: 31115032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.
    Bouchez S; Fedele F; Giannakoulas G; Gustafsson F; Harjola VP; Karason K; Kivikko M; von Lewinski D; Oliva F; Papp Z; Parissis J; Pollesello P; Pölzl G; Tschöpe C
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):617-624. PubMed ID: 30402660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure.
    Nieminen MS; Fonseca C; Brito D; Wikström G
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C15-C21. PubMed ID: 29249906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan improves cardiac function, hemodynamics, and body inflammation in patients with acute myocardial infarction and heart failure.
    Sun X; Wei C; Li L; Qu C
    Am J Transl Res; 2023; 15(9):5624-5632. PubMed ID: 37854215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced heart failure: a contemporary approach.
    Chun KH; Kang SM
    Korean J Intern Med; 2023 Jul; 38(4):471-483. PubMed ID: 37369524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Palliative aspects in clinical acute and emergency medicine as well as intensive care medicine : Consensus paper of the DGIIN, DGK, DGP, DGHO, DGfN, DGNI, DGG, DGAI, DGINA and DG Palliativmedizin].
    Michels G; John S; Janssens U; Raake P; Schütt KA; Bauersachs J; Barchfeld T; Schucher B; Delis S; Karpf-Wissel R; Kochanek M; von Bonin S; Erley CM; Kuhlmann SD; Müllges W; Gahn G; Heppner HJ; Wiese CHR; Kluge S; Busch HJ; Bausewein C; Schallenburger M; Pin M; Neukirchen M
    Med Klin Intensivmed Notfmed; 2023 Dec; 118(Suppl 1):14-38. PubMed ID: 37285027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.